BRIEF published on 09/13/2024 at 08:05, 2 months 8 days ago Mountain Alliance AG Releases Half-Year Financial Report 2024 Net Asset Value Half-year Results Mountain Alliance AG AlphaPet Exit Lingoda Growth
PRESS RELEASE published on 09/13/2024 at 08:00, 2 months 8 days ago Mountain Alliance AG publishes half-year financial statements 2024 - Net asset value per share at € 6.67 Mountain Alliance AG published half-year financial statements for 2024, reporting a net asset value per share of €6.67. Successful exits and portfolio growth highlighted Net Asset Value Portfolio Growth Mountain Alliance AG Half-year Financial Statements Exit Options
BRIEF published on 05/24/2024 at 09:05, 5 months 28 days ago Mountain Alliance Sells Entire Stake in AlphaPet and Realizes Further Profit Investment Profit Stake Sale Mountain Alliance AG AlphaPet Ventures GmbH
PRESS RELEASE published on 05/24/2024 at 09:00, 5 months 28 days ago Mountain Alliance sells entire stake in AlphaPet and realises further profit Mountain Alliance AG sells entire stake in AlphaPet Ventures GmbH, realizing further profit. The transaction is expected to be finalized shortly Venture Capital Stake Sale Mountain Alliance AG AlphaPet Ventures GmbH Profit Realization
BRIEF published on 05/07/2024 at 10:05, 6 months 14 days ago Mountain Alliance AG Announces 2023 Annual Report with NAV per Share at €6.64 Investment Strategy Net Asset Value Lingoda Annual Report 2023 Mountain Alliance AG
PRESS RELEASE published on 05/07/2024 at 10:00, 6 months 14 days ago Mountain Alliance AG publishes Annual Report 2023 – Net Asset Value per share at € 6.64 Mountain Alliance AG publishes Annual Report 2023 with Net Asset Value per share at €6.64. Strategic sale of listed investments and focus on venture capital market for expansion Net Asset Value Annual Report Investments Mountain Alliance AG Venture Capital Market
PRESS RELEASE published on 09/20/2023 at 08:00, 1 year 2 months ago Mountain Alliance AG publishes half-year report 2023 – NAV per share at € 6.91
PRESS RELEASE published on 05/10/2023 at 08:00, 1 year 6 months ago Mountain Alliance AG publishes Annual Report 2022 - Three successful exits, core portfolio further developed - NAV per share at € 6.89
PRESS RELEASE published on 03/01/2023 at 08:00, 1 year 8 months ago Mountain Alliance AG: Investment AlphaPet acquires leading organic premium pet food brand Herrmann's Manufaktur
Published on 11/21/2024 at 10:03, 36 minutes ago Pixotope Launches Revolutionary AI-Powered Graphics Integration Tool for Broadcast Industry
Published on 11/21/2024 at 10:00, 39 minutes ago BluSky Carbon JV Entity BluMountain Enters into JV Partnership in Southeastern USA
Published on 11/21/2024 at 09:00, 1 hour 39 minutes ago ProScore Announces Domestic Content Solution for Inflation Reduction Act Requirements
Published on 11/21/2024 at 00:35, 10 hours 4 minutes ago Vision Marine Technologies Establishes a Strategic Hub for Electric Boat Sales, Rentals, and Distribution, Marking a Milestone at Dania Pointe’s Grand Opening of Aileron Residences
Published on 11/21/2024 at 00:25, 10 hours 14 minutes ago Biomind Labs Welcomes U.S. Policy Shift as a Historic Milestone for Psychedelic Therapies
Published on 11/21/2024 at 10:04, 34 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:02, 37 minutes ago Supervisory Board appoints Carsten Schmitt as new CFO
Published on 11/21/2024 at 10:00, 39 minutes ago Nabaltec AG continues solid earnings performance in third quarter of 2024
Published on 11/21/2024 at 10:00, 39 minutes ago Deutsche Beteiligungs AG: Successful final closing of DBAG ECF IV
Published on 11/21/2024 at 09:01, 1 hour 38 minutes ago Original-Research: Netfonds AG (von NuWays AG): Buy
Published on 11/21/2024 at 06:58, 3 hours 41 minutes ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 15 hours 19 minutes ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 16 hours 54 minutes ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 16 hours 54 minutes ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
Published on 11/20/2024 at 07:45, 1 day 2 hours ago Gimv sells to Fremman Capital a majority stake in outpatient rehabilitation specialist rehaneo
